Corticosteroid-use in primary and secondary brain tumour patients: a review

被引：38
|
作者：
Ryan, Richella [1 ]
Booth, Sara [1 ,2 ,3 ]
Price, Stephen [2 ,4 ]
机构：
[1] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Palliat Care Dept, Cambridge CB2 0QQ, England
[2] Univ Cambridge, Cambridge, England
[3] Kings Coll London, London WC2R 2LS, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 0QQ, England
来源：
JOURNAL OF NEURO-ONCOLOGY | 2012年 / 106卷 / 03期
关键词：
Brain neoplasms; Corticosteroids; Quality of life; GLUCOCORTICOID-RECEPTOR GENE; ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; DEXAMETHASONE TREATMENT; CAPILLARY-PERMEABILITY; VASCULAR-PERMEABILITY; INDUCED OSTEOPOROSIS; PHASE-II; EDEMA; EXPRESSION;
D O I：
10.1007/s11060-011-0713-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Corticosteroids have been effective in the management of cerebral oedema, in the context of brain tumours, for many decades. Though their effectiveness is well-established, this needs to be balanced against their potential to cause significant side effects. There is currently little consensus in the literature about how this should be done. This article reviews the literature, specifically in relation to the role of corticosteroids in primary and secondary brain tumour patients. Areas reviewed include corticosteroid pharmacology, indications, mechanism of action, toxicity profile, prescribing practices, and corticosteroid-sparing agents.
引用
收藏
页码：449 / 459
页数：11
相关论文
共 50 条
  • [21] Functional rehabilitation and brain tumour patients. A review of outcome
    Giordana, M. T.
    Clara, E.
    NEUROLOGICAL SCIENCES, 2006, 27 (04) : 240 - 244
  • [22] Functional rehabilitation and brain tumour patients. A review of outcome
    M. T. Giordana
    E. Clara
    Neurological Sciences, 2006, 27 : 240 - 244
  • [23] THE COST OF INPATIENT CARE FOR ADULT PRIMARY BRAIN TUMOUR PATIENTS IN ENGLAND
    Kanso, N.
    Le Calvez, K.
    Mauricaite, R.
    Williams, M.
    NEURO-ONCOLOGY, 2022, 24
  • [24] PRIMARY BRAIN TUMOUR AS SECOND NEOPLASMA IN PATIENTS WITH EXTRACRANIAL CANCER HISTORY
    Kalita, Ondrej
    Vaverka, Miroslav
    Hrabalek, Lumir
    Zlevorova, Miloslava
    Trojanec, Radek
    Hajduch, Marian
    Kneblova, Magdalena
    Ehrmann, Jiri, Jr.
    NEURO-ONCOLOGY, 2013, 15 : 114 - 114
  • [25] Making use of the primary tumour
    Baars, A
    Buter, J
    Pinedo, HM
    BIOESSAYS, 2003, 25 (01) : 79 - 86
  • [26] Primary malignant rhabdoid tumour of the brain
    Howlett, DC
    Jarosz, JM
    Stewart, RAL
    Bingham, JB
    Cox, TCS
    CLINICAL RADIOLOGY, 1996, 51 (07) : 525 - 526
  • [27] Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim
    Michel, Marc
    Boekhorst, Peter A. W. Te
    Janssens, Ann
    Pabinger-Fasching, Ingrid
    Sanz, Miguel A.
    Nie, Kun
    Kreuzbauer, Georg
    HEMATOLOGY, 2011, 16 (05) : 274 - 277
  • [28] Primary brain tumors as a secondary malignancy in patients with systemic cancer
    Blumenthal, DT
    DeAngelis, LM
    ANNALS OF NEUROLOGY, 1997, 42 (03) : M153 - M153
  • [29] A Practice Pilot Survey on the Current Use of Corticosteroid Therapy in Brain Tumor Patients
    Panda, Pankaj K.
    Gupta, Tejpal
    Jalali, Rakesh
    NEUROLOGY INDIA, 2022, 70 (05) : 1896 - +
  • [30] Isolated Knee Osteonecrosis Secondary to Corticosteroid Use in Two Patients with Idiopathic Thrombocytopenic Purpura
    Yagci, Ilker
    Agirman, Mehmet
    Akyuz, Guelseren
    TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2010, 56 (02): : 94 - 96
12345